Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell crawled date : 2021 - 04 - 23 save search
ADC Therapeutics Announces FDA Approval of ZYNLONTA™ (loncastuximab tesirine-lpyl) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published: 2021-04-23 (Crawled : 23:00) - biospace.com/
ADCT | $4.76 -4.23% 210K
|
Health Technology
|
| O: 1.84%
H: 8.65%
C: -6.44%
fda fda approval approval t-cell
FDA grants accelerated approval to loncastuximab tesirine-lpyl for large B-cell lymphoma
Published: 2021-04-23 (Crawled : 18:42) - fda.gov
ADCT | $4.76 -4.23% 210K
|
Health Technology
| Email alert
Add to watchlist
fda approval granted grant t-cell
Gamma Delta T Cell Cancer Immunotherapy Clinical Research Trials Pipeline Outlook 2026
Published: 2021-04-23 (Crawled : 14:15) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 3.38%
H: 10.07%
C: 9.93%
immunotherapy therapy cancer research trial t-cell
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M
|
Consumer Services
CZOO | $11.04 121.24% 11M
|
LICN | $0.9107 62.63% 14M
|
BOF | $1.87 59.83% 100M
|
AMST | $3.18 59.0% 67M
|
Technology Services
SKIL 4 | $8.72 52.72% 410K
|
Information
MTC | $3.31 47.77% 7.7M
|
Technology Services
MULN | News | $3.915 43.41% 12M
|
Information
WIMI | $1.04 43.37% 17M
|
Technology Services
RILY | $29.755 36.99% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.